Date26th, Aug 2023

Summary:

Viewing proteins at the nanoscale offers insights for treating neurodegenerative diseases.

Full text:

Nanoscale Scan Image Showing Protein Condensate Interaction

Researchers have employed advanced optical techniques to study the formation of protein aggregates associated with neurodegenerative diseases. By analyzing an ALS-related protein, they’ve gained unprecedented insight into the liquid-to-solid protein transition, shedding light on conditions like Alzheimer’s and ALS. Above is a nanoscale scan image showing protein condensate interaction. Credit: The University of Sydney

Viewing proteins at the nanoscale offers insights for treating neurodegenerative diseases.

Many diseases affecting the brain and nervous system are linked to the formation of protein aggregates, or solid condensates, in cells from their liquid form condensate, however, little is known about this process.

This liquid-to-solid transition can trigger the formation of what are called amyloid fibrils. These can further form plaques in neurons causing neurodegenerative diseases such as Alzheimer’s.

Biomedical engineers at the University of Sydney, in collaboration with scientists at the University of Cambridge and Harvard University, have now developed sophisticated optical techniques to monitor at close range the process by which these protein aggregates form.

By testing a protein associated with Amyotrophic Lateral Sclerosis – ALS disease, which affected astrophysicist Professor Stephen Hawking – the Sydney engineers closely monitored the transition of this protein from its liquid to solid phase.